Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of ...

Ivana Magovčević-Liebisch President and CEO, Dr Magovčević-Liebisch is an accomplished pharmaceutical and biotechnology ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

LEO Pharma, a leader in medical dermatology, today announces the appointment of Sophie Lamle, D.Phil, as new Executive Vice President (EVP) of Development. Sophie will join the Global Leadership Team ...

Northern Ireland offers Indian companies a strategic gateway to Great Britain and European markets, boasting a skilled ...

The US Food and Drug Administration (FDA) has issued a recall of approximately 580,000 bottles of a commonly prescribed blood pressure medication after tests revealed the presence of a potential ...

If you take prazosin for high blood pressure or PTSD, it’s time to double-check your prescription. The FDA confirmed that more than 580,000 bottles of the drug have been pulled […] The post Consumers ...

Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide recalls of more than ...

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences ...

Tower and Teva led the gains today as Bank Leumi declined. The Tel Aviv Stock Exchange rose today. The Tel Aviv 35 Index rose 0.45% to 3,288.20 points, the Tel Aviv 125 Index rose 0.74% to 3,363.38 ...

For manufacturers, the tinea pedis treatment market offers a resilient, expanding, and innovation-driven ecosystem. With a projected CAGR of 5.2% through 2035, the sector presents sustained ...